Skip to main content

Advertisement

Fig. 5 | BMC Geriatrics

Fig. 5

From: Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

Fig. 5

Scatterplots of covariates related to study outcomes. The effect of baseline functional ability on all-cause discontinuation (Top), the effect of baseline functional ability on discontinuation due to AE (Middle) and the effect of baseline cognitive function on neuropsychiatric symptoms (Bottom)

Back to article page